InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the detailed record of transactions filed by Michael Grosse, Président. Director active across 1 companies, notably Sartorius Stedim Biotech. Aggregated, 1 disclosures have been logged. Total volume traded: €158.3m. The latest transaction was disclosed on 10 December 2025 — Cession. Regulator: AMF. The full history is openly available.
Declarations1 total
€158m750,000 shares@ €211.100.77% mcap100.0% of flow
ActionHors plateforme de négociation
2025DD1074245·
1 of 1 declaration
About Michael Grosse
Michael Grosse is the Chairman of Sartorius Stedim Biotech, a company specializing in solutions for the biopharmaceutical industry. As chairman, he oversees the company's activities and contributes to its growth strategy. Sartorius Stedim Biotech is recognized for its innovations in the biotechnology field.
